The Role of the Advanced Practitioner in Maintaining Adherence in Patients on Oral Oncolytics

Posted: 12/8/2017
Expires: 12/7/2018
Estimated time to complete: 1 hour

This activity is supported by unrestricted educational grants from AstraZeneca; Bayer HealthCare Pharmaceuticals Inc.; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Novartis Pharmaceutical Corporation; and Taiho Oncology, Inc.

This CME/CE/CPE accredited activity is jointly provided by


Instructions for Earning CE credit

This activity has expired, credit is no longer available.

Please visit the Oral Oncolytics Adherence Knowledge Center at:

rowCount++; var rowCount = 0; rowCount++;

Copyright © 2010-2021 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.